Capping biological quantum dots with the peptide CLPFFD to increase stability and to reduce effects on cell viability
- 226 Downloads
Highly fluorescent nanoparticles, or quantum dots, have multiple applications in biology and biomedicine; however, in most cases, it is necessary to functionalize them to enhance their biocompatibility and selectivity. Generally, functionalization is performed after nanoparticle synthesis and involves the use of molecules or macromolecules having two important traits: specific biological activity and functional groups that facilitate nanoparticle capping (i.e. atom–atom interaction). For this reason, we carried out a simple protocol for the chemical synthesis of cadmium telluride quantum dots capped with glutathione, and we then functionalized these nanoparticles with the amphipathic peptide CLPFFD. This peptide attaches selectively to β-Amyloid fibres, which are involved in Alzheimer’s disease. Our results show that the optical properties of the quantum dots are not affected by functionalization with this peptide. Infrared spectra showed that cadmium telluride quantum dots were functionalized with the peptide CLPFFD. In addition, no significant differences were observed between the surface charge of the quantum dots with or without CLPFFD and the nanocrystal size calculated for HR-TEM was 4.2 nm. Finally, our results show that quantum dots with CLPFFD are stable and that they resulted in a significantly reduced cytotoxicity with respect to that induced by quantum dots not conjugated with the peptide. Moreover, the results show that the CLPFFD-functionalized nanoparticles bind to β-Amyloid fibres.
KeywordsCadmium telluride quantum dots β-Amyloid fibres Peptide CLPFFD Cell viability
Financial support of this paper was provided by the FONDECYT 3130654; Fondap 15130011 and FONDECYT 1130425 Grants.
- Bieschke J, Siegel SJ, Fu Y, Kelly JW (2008) Alzheimer’s Aβ peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)? Biochemistry 47:50–59. doi: 10.1021/bi701757v CrossRefGoogle Scholar
- Huang Y-Y et al. (2012) Can nanotechnology potentiate photodynamic therapy? vol 1. doi: 10.1515/ntrev-2011-0005
- Let there be light (2015) Nat Mater 14:453. doi: 10.1038/nmat4287
- Patra S, Samanta A (2014) Effect of capping agent and medium on light-induced variation of the luminescence properties of CdTe quantum dots: a study based on fluorescence correlation spectroscopy, steady state and time-resolved fluorescence techniques. J Physic Chem C 118:18187–18196. doi: 10.1021/jp5048216 CrossRefGoogle Scholar
- Pérez-Donoso JM et al (2012) Biomimetic. Mild chemical synthesis of cdte-gsh quantum dots with improved biocompatibility PLoS One 7:e30741–e30749Google Scholar
- Vera AM, Cárcamo JJ, Aliaga AE, Gómez-Jeria JS, Kogan MJ, Campos-Vallette MM (2015) Interaction of the CLPFFD peptide with gold nanospheres. A Raman, surface enhanced Raman scattering and theoretical study. Spectrochimica Acta Part A: Mol Biomol Spectrosc 134:251–256. doi: 10.1016/j.saa.2014.06.116 CrossRefGoogle Scholar